Predictors of impulsivity and reward seeking behavior with dopamine agonists

Parkinsonism and Related Disorders

Volumn 14, Issue 1, 2008, Pages 28-32

  Ondo, William G ^a   Lai, Dejian ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c JIANGXI UNIVERSITY OF FINANCE AND ECONOMICS   (China)

Author keywords

Dopamine agonist; Gambling; Parkinson's disease; Restless legs syndrome; Reward mechanism

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMPULSIVENESS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESTLESS LEGS SYNDROME; REWARD; RISK FACTOR; SEXUAL BEHAVIOR;

AGE FACTORS; DOPAMINE AGONISTS; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PARKINSON DISEASE; RESTLESS LEGS SYNDROME; REWARD; RISK FACTORS; SEX FACTORS;

EID: 38349168959     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.05.006     Document Type: Article

References (47)

1. Lu C., Bharmal A., and Suchowersky O. Gambling and Parkinson disease. Arch Neurol 63 (2006) 298
2. Stocchi F. Pathological gambling in Parkinson's disease. Lancet Neurol 4 (2005) 590-592
3. Dodd M.L., Klos K.J., Bower J.H., Geda Y.E., Josephs K.A., and Ahlskog J.E. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62 (2005) 1377-1381
4. Stein D.J., and Grant J.E. Betting on dopamine. CNS Spectr 10 (2005) 268-270
5. Avanzi M., Uber E., and Bonfa F. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease. Neurol Sci 25 (2004) 98-101
6. Driver-Dunckley E., Samanta J., and Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 61 (2003) 422-423
7. Montastruc J.L., Schmitt L., and Bagheri H. Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine. Rev Neurol (Paris) 159 (2003) 441-443
8. Gschwandtner U., Aston J., Renaud S., and Fuhr P. Pathologic gambling in patients with Parkinson's disease. Clin Neuropharmacol 24 (2001) 170-172
9. Molina J.A., Sainz-Artiga M.J., Fraile A., Jimenez-Jimenez F.J., Villanueva C., Orti-Pareja M., et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?. Mov Disord 15 (2000) 869-872
10. Seedat S., Kesler S., Niehaus D.J., and Stein D.J. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 11 (2000) 185-186
11. Voon V., Hassan K., Zurowski M., Duff-Canning S., de Souza M., Fox S., et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66 (2006) 1750-1752
12. Imamura A., Uitti R.J., and Wszolek Z.K. Dopamine agonist therapy for Parkinson disease and pathological gambling. Parkinsonism Relat Disord (2006)
13. Tippmann-Peikert M., Park J.G., Boeve B.F., Shepard J.W., and Silber M.H. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 68 (2007) 301-303
14. Quickfall J., and Suchowersky O. Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism Relat Disord (2007)
15. Evans A.H., and Butzkueven H. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Mov Disord (2007)
16. Evans A.H., and Lees A.J. Dopamine dysregulation syndrome in Parkinson's disease. Curr Opin Neurol 17 (2004) 393-398
17. Giovannoni G., O'Sullivan J.D., Turner K., Manson A.J., and Lees A.J. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68 (2000) 423-428
18. Kunig G., Leenders K.L., Martin-Solch C., Missimer J., Magyar S., and Schultz W. Reduced reward processing in the brains of Parkinsonian patients. Neuroreport 11 (2000) 3681-3687
19. Menza M.A., Golbe L.I., Cody R.A., and Forman N.E. Dopamine-related personality traits in Parkinson's disease. Neurology 43 (1993) 505-508
20. American Psychiatric Association. Diagnosis and statistical manual of mental disorders. 4th ed. (2000), American Psychiatric Association, Washington, DC
21. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63 (2006) 969-973
22. Pontone G., Williams J.R., Bassett S.S., and Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67 (2006) 1258-1261
23. Voon V., Thomsen T., Miyasaki J.M., de Souza M., Shafro A., Fox S.H., et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64 (2007) 212-216
24. Ondo W.G., Vuong K.D., and Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59 (2002) 421-424
25. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 (2003) 101-119
26. Shahed J., Davidson T., and Jankovic J. Craving sweets in Parkinson's disease. Mov Disord 21 (2006) S599
27. Evans A.H., Lawrence A.D., Potts J., Appel S., and Lees A.J. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65 (2005) 1570-1574
28. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38 (1995) 95-137
29. Bergh C., Eklund T., Sodersten P., and Nordin C. Altered dopamine function in pathological gambling. Psychol Med 27 (1997) 473-475
30. Roy A., Adinoff B., Roehrich L., Lamparski D., Custer R., Lorenz V., et al. Pathological gambling. A psychobiological study. Arch Gen Psychiatry 45 (1988) 369-373
31. Comings D.E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Chen C., et al. The additive effect of neurotransmitter genes in pathological gambling. Clin Genet 60 (2001) 107-116
32. Blanco C., Orensanz-Munoz L., Blanco-Jerez C., and Saiz-Ruiz J. Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry 153 (1996) 119-121
33. Carrasco J.L., Saiz-Ruiz J., Hollander E., Cesar J., and Lopez-Ibor Jr. J.J. Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatr Scand 90 (1994) 427-431
34. Blum K., Braverman E.R., Wu S., Cull J.G., Chen T.J., Gill J., et al. Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry 2 (1997) 239-246
35. Comings D.E., Gade R., Wu S., Chiu C., Dietz G., Muhleman D., et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 2 (1997) 44-56
36. Comings D.E., Gonzalez N., Wu S., Gade R., Muhleman D., Saucier G., et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet 88 (1999) 358-368
37. Noble E.P. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 1 (2000) 309-333
38. Martin-Soelch C., Leenders K.L., Chevalley A.F., Missimer J., Kunig G., Magyar S., et al. Reward mechanisms in the brain and their role in dependence: evidence from neurophysiological and neuroimaging studies. Brain Res Brain Res Rev 36 (2001) 139-149
39. Schultz W. Getting formal with dopamine and reward. Neuron 36 (2002) 241-263
40. Zald D.H., Boileau I., El-Dearedy W., Gunn R., McGlone F., Dichter G.S., et al. Dopamine transmission in the human striatum during monetary reward tasks. J Neurosci 24 (2004) 4105-4112
41. Stojanov W., Karayanidis F., Johnston P., Bailey A., Carr V., and Schall U. Disrupted sensory gating in pathological gambling. Biol Psychiatry 54 (2003) 474-484
42. Elliott R., Newman J.L., Longe O.A., and Deakin J.F. Differential response patterns in the striatum and orbitofrontal cortex to financial reward in humans: a parametric functional magnetic resonance imaging study. J Neurosci 23 (2003) 303-307
43. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., et al. Evidence for striatal dopamine release during a video game. Nature 393 (1998) 266-268
44. Potenza M.N., Steinberg M.A., Skudlarski P., Fulbright R.K., Lacadie C.M., Wilber M.K., et al. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry 60 (2003) 828-836
45. Goudriaan A.E., Oosterlaan J., de Beurs E., and Van den Brink W. Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 28 (2004) 123-141
46. Petry N.M. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol 110 (2001) 482-487
47. Potenza M.N., and Winters K.C. The neurobiology of pathological gambling: translating research findings into clinical advances. J Gambl Stud 19 (2003) 7-10